128 related articles for article (PubMed ID: 15769511)
1. Structural observation of complexes of FGF-2 and regioselectively desulfated heparin in aqueous solutions.
Yuguchi Y; Kominato R; Ban T; Urakawa H; Kajiwara K; Takano R; Kamei K; Hara S
Int J Biol Macromol; 2005 Mar; 35(1-2):19-25. PubMed ID: 15769511
[TBL] [Abstract][Full Text] [Related]
2. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
[TBL] [Abstract][Full Text] [Related]
3. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
[TBL] [Abstract][Full Text] [Related]
4. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.
Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J
FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857
[TBL] [Abstract][Full Text] [Related]
5. Heparin structures in FGF-2-dependent morphological transformation of astrocytes.
Nagayasu T; Miyata S; Hayashi N; Takano R; Kariya Y; Kamei K
J Biomed Mater Res A; 2005 Sep; 74(3):374-80. PubMed ID: 15973728
[TBL] [Abstract][Full Text] [Related]
6. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.
Guimond S; Maccarana M; Olwin BB; Lindahl U; Rapraeger AC
J Biol Chem; 1993 Nov; 268(32):23906-14. PubMed ID: 7693696
[TBL] [Abstract][Full Text] [Related]
7. Variability in the carbazole assay for N-desulfonated/N-acylated heparin derivatives.
Hattan CM; Kerns RJ
Carbohydr Res; 2007 Dec; 342(17):2664-9. PubMed ID: 17850773
[TBL] [Abstract][Full Text] [Related]
8. Structural specificity of heparin binding in the fibroblast growth factor family of proteins.
Raman R; Venkataraman G; Ernst S; Sasisekharan V; Sasisekharan R
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2357-62. PubMed ID: 12604799
[TBL] [Abstract][Full Text] [Related]
9. Depiction of the forces participating in the 2-O-sulfo-alpha-L-iduronic acid conformational preference in heparin sequences in aqueous solutions.
Pol-Fachin L; Verli H
Carbohydr Res; 2008 Jul; 343(9):1435-45. PubMed ID: 18452898
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
[TBL] [Abstract][Full Text] [Related]
11. Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor. FGF-1 recognizes both the (1)C(4) and (2)S(O) conformations of a bioactive heparin-like hexasaccharide.
Canales A; Angulo J; Ojeda R; Bruix M; Fayos R; Lozano R; Giménez-Gallego G; Martín-Lomas M; Nieto PM; Jiménez-Barbero J
J Am Chem Soc; 2005 Apr; 127(16):5778-9. PubMed ID: 15839662
[TBL] [Abstract][Full Text] [Related]
12. Infrared spectroscopy of heparins suggests that the region 750-950 cm-1 is sensitive to changes in iduronate residue ring conformation.
Grant D; Long WF; Moffat CF; Williamson FB
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):193-7. PubMed ID: 2018474
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
[TBL] [Abstract][Full Text] [Related]
14. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
Harmer NJ
Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
[TBL] [Abstract][Full Text] [Related]
15. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2.
Ishihara M; Takano R; Kanda T; Hayashi K; Hara S; Kikuchi H; Yoshida K
J Biochem; 1995 Dec; 118(6):1255-60. PubMed ID: 8720143
[TBL] [Abstract][Full Text] [Related]
16. An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2.
Cochran S; Li CP; Bytheway I
Chembiochem; 2005 Oct; 6(10):1882-90. PubMed ID: 16175541
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
Ishihara M
Glycobiology; 1994 Dec; 4(6):817-24. PubMed ID: 7537556
[TBL] [Abstract][Full Text] [Related]
18. Ordering of lipid A-monophosphate clusters in aqueous solutions.
Faunce CA; Reichelt H; Quitschau P; Paradies HH
J Chem Phys; 2007 Sep; 127(11):115103. PubMed ID: 17887884
[TBL] [Abstract][Full Text] [Related]
19. Structure and dynamics of sulfate ion in aqueous solution--an ab initio QMCF MD simulation and large angle X-ray scattering study.
Vchirawongkwin V; Rode BM; Persson I
J Phys Chem B; 2007 Apr; 111(16):4150-5. PubMed ID: 17402778
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of the binding of heparin to granulocyte colony-stimulating factor: importance of sulfate groups.
Liang A; Liu X; Du Y; Wang K; Lin B
Electrophoresis; 2008 Mar; 29(6):1286-90. PubMed ID: 18288776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
